Abstract
Flaxseed derivatives, including both oil and flax lignan, modify progression of renal injury in animal models, including Han:SPRD-cy polycystic kidney disease (PKD). Gender is a significant factor in the rates of progression of many forms of human renal disease, but the role of gender in the response to nutrition intervention in renal disease is unexplored. In this study, male and female Han:SPRD-cy rats or normal littermates were fed either corn oil (CO) or flax oil (FO) diets, with or without 20 mg/kg of the diet flax lignan secoisolaricinoresinol dyglycoside (SDG). Renal injury was assessed morphometrically and biochemically. Renal and hepatic PUFA composition was assessed by GC and renal PGE2 release by ELISA. FO preserved body weight in PKD males, with no effect in females. SDG reduced weight in both normal and PKD females. FO reduced proteinuria in both male and female PKD. FO reduced cystic change and renal inflammation in PKD males but reduced cystic change, fibrosis, renal inflammation, tissue lipid peroxides, and epithelial proliferation in PKD females. SDG reduced renal inflammation in all animals and lipid peroxides in PKD fenales. A strong interaction between SDG and FO was observed in renal FA composition of female kidneys only, suggesting increased conversion of C18 PUFA to C20 PUFA. FO reduced renal release of PGE2 in both genders. Gender influences the effects of flaxseed derivatives in Han:SPRD-cy rats. Gender-based responses to environmental factors, such as dietary lipid sources and micronutrients, may contribute to gender-based differences in disease progression rates.
Similar content being viewed by others
Abbreviations
- ARA:
-
arachidonic acid
- ALA:
-
α-linolenic acid
- CO:
-
corn oil
- FO:
-
flax oil
- LNA:
-
linoleic acid
- ox-LDL:
-
oxidized low density lipoprotein
- PCNA:
-
proliferating cell nuclear antigen
- PKD:
-
polycytsis kindey disease
- SDG:
-
secoisolaricinoresinol dyglycoside
References
Burrowes, J.D., and Van Houten, G. (2005) Use of Alternative Medicine by Patients with Stage 5 Chronic Kidney Disease, Adv. Chronic Kidney Dis. 12, 312–325.
Bierrnbaum, M.L., Reichstein, R., and Watkins, T.R. (1993) Reducing Atherogeneic Risk in Hyperlipemic Humans with Flax Seed Supplementation: A Preliminary Report, J. Am. Coll. Nutr. 12, 501–504.
Ford, J.D., Huang, K.S., Wang, H.B., Davin, L.B., and Lewis, N.G. (2001) Biosynthetic Pathways to the Cancer Chemopreventive Secoisolaricirestionol Diglucoside-Hydrozymethyl Glutaryl Ester-Linked Lignan Oligomers in Flax (Linum usitatissimum) Seed, J. Nat. Prod. 64, 1388–1397.
Jenkins, D.J., Kendall, C.W., Vidgen, E., Agarwal, S., Rao, A.V., Rosenberg, R.S., Diamandis, E.P., Novokmet, R., Mehling, C.C., Perera, T., Griffin, L.C., and Cunnane, S.C. (1999) Health Aspects of Partially Defatted Flaxssed, Including Effects on Serum Lipids, Oxidative Measures, and ex vivo Androgen and Progestin Activity: A Controlled Crossover Trial, Am. J. Clin. Nutr. 69, 395–402.
Prasad, K. (1997) Dietary Flax Seed in Prevention of Hypercholesterolemic Atherosclerosis, Atherosclerosis 132, 69–76.
Rossetti, R.G., Seiler, C.M., DeLuca, P, Laposata, M., and Zurier, R.B. (1997) Oral Administration of Unsaturated Fatty Acids: Effects on Human Peripheral Blood T Lymphocyte Proliferation, J. Leukoc. Biol. 62, 438–443.
Gibson, R.A., Neumann, M.A., James, M.J., Hawkes, J.S., Hall, C., and Cleland, L.G. (1992) Effect on n−3 and n−6 Dietary Fats on the Lipoxygenase Products from Stimulated Rat Neutrophils, Prostaglandins Leukot. Essent. Fatty Acids 46, 87–91.
Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G., and James, M.J. (1996) The Effect on Human Tumor Necrosis Factor Alpha and Interleukin 1 Beta Production of Diets Enriched in n−3 Fatty Acids from Vegetable Oil or Fish Oil, Am. J. Clin. Nutr. 63, 116–122.
Borriello, S.P., Setchell, K.D., Axelson, M., and Lawson, A.M. (1985) Production and Metabolism of Lignans by the Human Fecal Flora, J. Appl. Bacteriol. 58, 37–43.
Kurzer, M.S., and Xu, X. (1997) Dietary Phytoestrogents, Annu. Rev. Nutr. 17, 353–381.
Velasquez, M.T., Bhathena, S.J., Ranich, T., Schwartz, A.M., Kardon, D.E., Ali, A.A., Haudenschild, C.C., and Hansen, C.T. (2003) Dietary Flaxssed Meal Reduces Proteinuria and Ameliorates Neuphropathy in an Animal Model of Type II Diabetes Mellitus, Kidney Int. 64, 2100–2107.
Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Buist, R., and Peeling, J. (1998) The Effect of Dietary Flaxssed Supplemantation on Organic Anion and Osmolyte Content and Excretion in Rat Polycystic Kidney Disease, Biochem. Cell Biol. 76, 553–559.
Ogborn, M.R., Nitschmann, E., Weiler, H., Leswick, D., and Bankovic-Calic, N. (1999) Flaxseed Ameliorates Interstitial Nephritis in Rat Polycystic Kidney Disease, Kidney Int. 55, 417–423.
Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Weiler, H.A., and Aukema, H. (2002) Dietary Flax Oil Reduces Renal Injury. Oxidized LDL Content, and Tissue n−6/n−3 FA Ratio in Experimental Polycystic Kidney Disease, Lipids 37, 1059–1065.
Ingram, A.J., Parbtani, A., Clark, W.F., Spanner, E., Huff, M.W., Philbrick, D.J., and Holub, B.J. (1995) Effects of Flaxseed and Flax Oil Diets in a Rat-5/6 Renal Ablation Model, Am. J. Kidney Dis. 25, 320–329.
Hall, A.V., Parbtani, A., Clark, W.F., Spanner, E., Keeney, M., Chin Yee, I., Philbrick, D.J., and Holub, B.J. (1993) Abrogation of MRL/lpr Lupus Nephritis by Dietary Flaxseed, Am. J. Kidney Dis. 22, 326–332.
Clark, W.F., Parbtani, A., Huff, M.W., Spanner, E., de Salis, H., Chin Yee, I., Philbrick, D.J., and Holub, B.J. (1995) Flaxssed: A Potential Treatment for Lupus Nephritis, Kidney Int. 48, 475–480.
Gabow, P.A., Johnson, A.M., Kaehny, W.D., Kimberling, W.J., Lezotte, D.C., Duley, I.T., and Jones, R.H. (1992) Factors Affecting the Progression of Renal Disease in Autosomal-Dominant Polycystic Kidney Disease, Kidney Int. 41, 1311–1319.
Magistroni, R., He, N., Wang, K., Andrew, R., Johnson, A., Gabow, P., Dicks, E., Parfrey, P., Torra, R., San-Millan, J.L., Coto, E., Van Dijk, M., Breuning, M., Peters, D., Bogdanova, N., Ligabue, G., Albertazzi, A., Hateboer, N., Demetriou, K., Pierides, A., Deltas, C., St. George-Hyslop, P., Ravine, D., and Pei, Y. (2003) Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease, J. Am. Soc. Nephrol. 14, 1164–1174.
Yium, J., Gabow, P., Johnson, A., Kimberling, W., and Martinez-Maldonado, M. (1994) Autosomal Dominant Polycystic Kidney Disease in Blacks: Clinical Course and Effects of Sickle-Cell Hemoglobin, J. Am. Soc. Nephrol. 4, 1670–1674.
Kausz, A.T., Obrador, G.T., Arora, P., Ruthazer, R., Levey, A.S., and Pereira, B.J. (2000) Late Initiation of Dialysis Among Women and Ethnic Minorities in the United States, J. Am. Soc. Nephrol. 11, 2351–2357.
Kang, A.K., and Miller, J.A. (2003) Impact of Gender on Renal Disease: the Role of the Renin Angiotensin System, Clin. Invest. Med. 26, 38–44.
Kang, D.H., Yu, E.S., Yoon, K.I., and Johnson, R. (2004) The Impact of Gender on Progression of Renal Disease: Potential Role of Estrogen-Mediated Vascular Endothelial Growth Factor Regulation and Vascular Protection, Am. J. Pathol. 164, 679–688.
Montezano, A.C., Callera, G.E., Mota, A.L., Fortes, Z.B., Nigro, D., Carvalho, M.H., Zorn, T.M., and Tostes, R.C. (2005) Endothelin-1 Contributes to the Sexual Differences in Renal Damage in DOCA-Salt Rats, Peptides 26, 1454–1462.
Neugarten, J., and Silbiger, S.R. (1995) Effects of Sex Hormones on Mesangial Cells, Am. J. Kidney Dis. 26, 147–151.
Reyes, D., Lew, S.Q., and Kimmel, P.L. (2005) Gender Differences in Hypertension and Kidney Disease, Med. Clin. North Am. 89, 613–630.
Modification of Diet in Renal Disease Study Group. (1995) Dietary Protein Restriction, Blood Pressure Control, and the Progression of Polycystic Kidney Disease, J. Am. Soc. Nephrol. 5, 2037–2047.
Knight, E.L., Stampfer, M.I., Hankinson, S.E., Spiegelman, D., and Curhan, G.C. (2003) The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency, Ann. Intern. Med. 138, 460–467.
Gretz, N., Ceccherini, I., Kranzlin, B., Kloting, I., Devoto, M., Rohmeiss, P., Hocher, B., Waldherr, R., and Romeo, G. (1995) Gender-Dependent Disease Severity in Autosomal Polycystic Kidney Disease of Rats, Kidney Int. 48, 496–500.
Cowley, B.D., Jr., Rupp, J.C., Muessel, M.J., and Gattone, V.H., II. (1997) Gender and the Effect of Gonadal Hormones on the Progression of Inherited Polycystic Kidney Disease in Rats, Am. J. Kidney Dis. 29, 265–272.
Ogborn, M.R., Nitschmann, E., Weiler, H.A., and Bankovic-Calic, N. (2000) Modification of Polycystic Kidney Disease and Fatty Acid Status by Soy Protein Diet, Kidney Int. 57, 159–166.
Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N., Weiler, H., and Aukema, H. (2005) Flax and Soy Phytoestrogen Effects on Renal Injury and Lipid Content in Experimental Polycystic Kidney Disease, J. Am. Nutr. Assoc. 8, 26–32.
Bosmans, J.L., Holvoet, P., Dauwe, S.E., Ysebaert, D.K., Chapelle, T., Jurgens, A., Kovacic, V., Van Marck, E.A., De Broe, M.E., and Verpooten, G.A. (2001) Oxidative Modification of Low-Density Lipoproteins and the Outcome of Renal Allografts at 1 1/2 Years, Kidney Int. 59, 2346–2356.
Uauy, R.D., Brich, D.G., Brich, E.E., Tyson, J.E., and Hoffman, D.R. (1990) Effect of Dietary Omega-3 Fatty Acids on Retinal Function of Very-Low-Birth-Weight Neonates, Pediatr. Res. 28, 485–492.
Mathias, M.M., and Dupont, J. (1985) Quantitative Relationships Between Dietary Linoleate and Prostaglandin (Eicosanoid) Biosynthesis, Lipids 20, 791–801.
Kivits, G.A., and Nugteren, D.H. (1988) The Urinary Excretion of Prostaglandins E and Their Corresponding Tetranor Metabolites by Rats Fed a Diet Rich in Eicosapentaneoate, Biochim. Biophys. Acta 958, 289–299.
Nagao, S., Kusaka, M., Nishii, K., Marunouchi, T., Kurahashi, H., Takahashi, H., and Grantham, J. (2005) Androgen Receptor Pathway in Rats with Autosomal Dominant Polycystic Kindey Disease, J. Am. Soc. Nephrol. 16, 2052–2062.
Zeier, M., Pohlmeryer, G., Deerberg, F., Schonherr, R., and Ritz, E. (1994) Progression of Renal Failure in the Han:SPRD Polycystic Kidney Rat, Nephrol. Dial. Transplant 9, 1734–1739.
Sullivan, J.C., Sasser, J.M., Pollock, D.M., and Pollock, J.S. (2005) Sexual Dimorphism in Renal Production of Prostanoids in Spontaneously Hypertensive Rats, Hypertension 45, 406–411.
Yang, T., Huang, Y.G., Ye, W., Hansen, P., Schnermann, J.B., and Briggs, J.P. (2005) Influence of Genetic Background and Gender on Hypertension and Renal Failure in COX-2-Deficient Mice, Am. J. Physiol. Renal Physiol. 288, F1125–1132.
Breyer, M.D., and Breyer, R.M. (2000) Prostaglandin E Receptors and the Kidney, Am. J. Physiol. Renal Physiol. 279, F12–23.
Vukicevic, S., Simic, P., Borovecki, F., Grguevic, L., Rogic, D., Orlic, I., Grasser, W.A., Thompson, D.D., and Paralker, V.M. (2006) Role of EP2 and EP4 Receptor-Selective Agonists of Prostaglandin E(2) in Acute and Chronic Kidney Failure, Kidney Int. 70, 1099–1106.
Eddy, A.A., and Giachelli, C.M. (1995) Renal Expression of Genes That Promote Interstitial Inflammation and Fibrosis in Rats with Protein-Overload Proteinuria, Keldney Int. 47, 1546–1557.
Frazier-Jessen, M., and Kovasc, E. (1995) Estrogen Modulation of JE/Monocyte Chemoattractant Protein-1 mRNA Expression in Murine Macrophages, J. Immunol. 154, 1838–1845.
Bankovic-Calic, N., Eddy, A., Sareen, S., and Ogborn, M.R. (1999) Renal Remodelling in Dietary, Protein Modified Rat Polycystic Kidney Disease, Pediatr. Nephrol. 13, 567–570.
Krepinsky, J., Ingram, A.J., James, L., Ly, H., Thai, K., Cattran, D.C., Miller, J.A., and Scholey, J.W. (2002) 17beta-Estradiol Modulates Mechanical Strain-Induced MAPK Activation in Mesangial Cells, J. Biol. Chem. 277, 9387–9394.
Concolino, G., Lubrano, C., Ombres, M., Santonati, A., Flammia, G.P., Di Silverio, F. (1993) Acquired Cystic Kidney Disease: The Hormonal Hypothesis, Urology 41, 170–175.
Silbiger, S.R., and Neugarten, J. (2003) The Role of Gender in the Progression of Renal Disease, Adv. Ren. Replace Ther. 10, 3–14.
Donadio, J.V., Jr. (2000) Use of Fish Oil to Treat Patients with Immunoglobulin a Nephropathy, Am. J. Clin. Nutr. 71, 373S-375S.
Clark, W.F., Muir, A.D., Westcott, N.D., and Parbtani, A. (2000) A Novel Treatment for Lupus Nephritis: Lignan Precursor Derived from Flax, Lupus 9, 429–436.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ogborn, M.R., Nitschmann, E., Bankovic-Calic, N. et al. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender. Lipids 41, 1141–1149 (2006). https://doi.org/10.1007/s11745-006-5064-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-006-5064-z